Economy
  • RU
  • KZ
  • RU
  • EN
  • KZ
  • News
  • Cars
  • Opinions
  • Business Guide
  • Stories
  • Kursiv Research
  • Lifestyle
  • SuperJournal
  • Economy
  • Sport
  • Editorial office
  • Advertising
  • Special projects
  • Kazakhstan
  • Uzbekistan
Economy
  • Resources
  • Investments
  • Banks & Finance
  • Real Estate

Investments

December 5, 2024

Fintech IDT Corporation gains on strong fiscal first-quarter financials

Maria Dranishnikova

Maria Dranishnikova

On Wednesday, December 4, shares of communications and payment services company IDT Corporation spiked in after-hours trading following the release of record earnings for the fiscal-2025 first quarter (ended October 31), which highlighted increasing profitability. Details In after-hours trading on Wednesday, IDT Corporation stock added more than 6% to $53.65…

Read more (~3 min.)

Share

  • Link copied
December 4, 2024

Zacks SCR reiterates 400% upside call on Nurexone Biologic for risk-tolerant investors

Maria Dranishnikova

Maria Dranishnikova

In a recent note, Zacks Small-Cap Research (Zacks SCR) has valued Canadian drug developer Nurexone Biologic, which trades in the U.S., at $2.55 per share, more than five times the current share price. In the over-the-counter market on Tuesday, December 3, the stock was quoted at $0.50 per share. Details  …

Read more (~3 min.)

Share

  • Link copied
December 4, 2024

‘Patriotic marketplace’ PublicSquare jumps 270% after Trump son joins board

Maria Dranishnikova

Maria Dranishnikova

On Tuesday, December 3, quotes on PSQ Holdings, the parent company of an online marketplace that brands itself as “anti-woke” and family oriented, surged 270% following the announcement that Donald Trump Jr. had joined the company’s board of directors. Details On Tuesday, PSQ Holdings (PublicSquare) stock spiked 270% on the…

Read more (~3 min.)

Share

  • Link copied
December 3, 2024

Archer Aviation shares plunge following Stellantis CEO resignation

Maria Dranishnikova

Maria Dranishnikova

Shares of air taxi developer Archer Aviation fell nearly 24% on Monday, December 2. Investors were likely spooked by the sudden resignation of the CEO of Stellantis, a major investor in Archer, reports Barron’s. Details On Monday, Archer Aviation stock dropped 23.7% on the New York Stock Exchange to close…

Read more (~5 min.)

Share

  • Link copied
December 3, 2024

Freedom Broker downgrades tow truck maker Miller Industries to ‘hold’

Maria Dranishnikova

Maria Dranishnikova

Freedom Broker has downgraded its rating for Miller Industries, a manufacturer of towing and recovery equipment, from “buy” to “hold” while reiterating its target price. It cited slowing sales growth but noted improvements in cash flow. Details In a note released in late November, Freedom Broker downgraded Miller Industries stock…

Read more (~3 min.)

Share

  • Link copied
December 2, 2024

Shares of gold miner Contango ORE plummet amid rising costs at Alaskan mine

Maria Dranishnikova

Maria Dranishnikova

Shares of gold exploration and mining company Contango ORE dropped nearly 22% on Friday, November 29, after the company announced higher than expected production costs at its Manh Choh mine, which it is developing in partnership with Canadian mining giant Kinross Gold. Details On Friday, Contango ORE stock fell almost…

Read more (~4 min.)

Share

  • Link copied
December 2, 2024

Zacks spotlights five small caps with ‘solid’ short-term upside

Maria Dranishnikova

Maria Dranishnikova

Zacks has recently put out a fresh batch of small-cap recommendations. While the five companies operate in different sectors, they have one thing in common — solid short-term upside, backed up by a favorable Zacks Rank. Talkspace Talkspace, with a market capitalization of $577.7 million, provides virtual mental health services…

Read more (~5 min.)

Share

  • Link copied
December 2, 2024

Applied Therapeutics plummets 76% after FDA declines to approve drug

Viktoriya Sirota

Viktoriya Sirota

On Friday, November 29, shares of the small-cap biopharmaceutical company Applied Therapeutics plummeted 76% after the FDA declined to approve its drug to treat a rare genetic metabolic disease, jeopardizing its plans to launch its first commercial product. Applied Therapeutics, which is also pursuing drug approval in Europe, says it…

Read more (~3 min.)

Share

  • Link copied
November 29, 2024

Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute

Maria Dranishnikova

Maria Dranishnikova

Zacks Small-Cap Research (Zacks SCR) sees MediciNova, which develops treatments for amyotrophic lateral sclerosis (ALS) and pulmonary fibrosis, as significantly undervalued. In a recent Zacks SCR note,  the stock’s fair value is estimated at $10 per share — five times its current price. MediciNova is set to receive compensation from pharmaceutical…

Read more (~3 min.)

Share

  • Link copied
November 28, 2024

Stock Trader’s Almanac sees jollier than usual Santa Claus rally for small caps

Maria Dranishnikova

Maria Dranishnikova

Small-cap stocks typically outperform the broader market from the Tuesday before Thanksgiving until the second trading day of the new year, points out Jeffrey Hirsch of Stock Trader’s Almanac. Historically, they have delivered stronger returns than their large-cap peers during this period, even with the so-called Santa Claus rally. Details…

Read more (~3 min.)

Share

  • Link copied
November 28, 2024

Stock price of small drone maker Unusual Machines doubles after Trump son joins board

Vladislav Osipov

Vladislav Osipov

Shares of U.S. drone manufacturer Unusual Machines, with a market capitalization of $75 million, more than doubled on Wednesday, November 27. The catalyst was the announcement that Donald Trump Jr., the son of the U.S. president-elect, had joined the company’s advisory board. Trump Jr. expressed his support for Unusual Machines’…

Read more (~3 min.)

Share

  • Link copied
November 27, 2024

The Motley Fool spotlights two small caps whose shares are held by Nvidia

Maria Dranishnikova

Maria Dranishnikova

The Motley Fool has highlighted two small-cap investments of the world’s second-most valuable company, the chipmaker Nvidia. According to Nvidia’s financials, it holds shares of voice assistant developer SoundHound AI and Applied Digital, a builder of data centers. The Motley Fool encourages investors to follow Nvidia’s lead. SoundHound AI With…

Read more (~3 min.)

Share

  • Link copied
November 27, 2024

Poseida Therapeutics, cell therapy maker, triples on Nasdaq after being acquired by Roche

Maria Dranishnikova

Maria Dranishnikova

Shares of Poseida Therapeutics, which develops cell and gene therapies for cancers and genetic diseases, skyrocketed nearly 230% on Tuesday, November 26. The surge came after the announcement of its acquisition by pharmaceutical giant Roche, with the deal valuing Poseida at $1.5 billion — triple its highest market value in…

Read more (~4 min.)

Share

  • Link copied
November 26, 2024

Cassava Sciences plummets after its Alzheimer’s drug fails in trials

Maria Dranishnikova

Maria Dranishnikova

On Monday, November 25, quotes on the small-cap biotech company Cassava Sciences plunged almost 84% after the company reported that its Alzheimer’s treatment had failed in a clinical trial. Details On Monday, Cassava Sciences stock lost almost 84% on the Nasdaq to $4.30 per share. This marked the biggest percentage…

Read more (~3 min.)

Share

  • Link copied
November 26, 2024

InvestorPlace Markets analyst highlights three small caps poised for a comeback in 2025

Maria Dranishnikova

Maria Dranishnikova

Thomas Yeung, an analyst at InvestorPlace Markets, has named three retreating small-cap stocks that he believes are poised for a turnaround in 2025. Two of the companies could benefit from the new administration of President-elect Donald Trump, while the third stands to gain from the trend of automation. Stratasys Stratasys,…

Read more (~3 min.)

Share

  • Link copied
November 26, 2024

‘The higher the crime rate, the higher the demand for our services’: An interview with Ituran’s CEO

Maria Dranishnikova

Maria Dranishnikova

“There’s no doubt: the higher the levels of crime and violence, the greater the demand for our services,” says Eyal Sheratzky, co-CEO of Ituran, in an exclusive interview with Kursiv.Investments. This Israeli company, with a market capitalization of almost $580 million on the Nasdaq, provides satellite vehicle-tracking services. It helps…

Read more (~9 min.)

Share

  • Link copied
November 25, 2024

Citius Pharma shares hit new low after reverse stock split

Maria Dranishnikova

Maria Dranishnikova

Shares of small-cap biopharmaceutical company Citius Pharmaceuticals plummeted nearly 19% on Friday, November 22, hitting an all-time low after the company announced a reverse stock split to regain compliance with listing requirements. Details Citius Pharma’s stock dropped 18.8% on the Nasdaq on Friday to close at $0.13 per share —…

Read more (~3 min.)

Share

  • Link copied
November 25, 2024

Royce spotlights three small-cap innovators reshaping their industries

Maria Dranishnikova

Maria Dranishnikova

Lauren Romeo, a portfolio manager of three Royce funds, has highlighted a trio of innovative smaller companies whose stocks are high-confidence holdings. She points out that technological advances often stem not just from giants like Nvidia and Amazon but also from small-cap companies. MKS Instruments The first company is MKS…

Read more (~4 min.)

Share

  • Link copied
November 22, 2024

Ready-made Asian food company DayDayCook briefly rallies as NYSE extends reporting deadline

Maria Dranishnikova

Maria Dranishnikova

Shares of Hong Kong-based ready-to-cook and ready-to-eat Asian food producer DayDayCook (DDC) rose nearly 10% on Thursday, November 21, following an announcement that the New York Stock Exchange had granted the company an extension to file its 2023 annual financial report. The new deadline is February 4, 2025. DDC has…

Read more (~3 min.)

Share

  • Link copied
November 22, 2024

Sidus Space gains after new partnership announced

Maria Dranishnikova

Maria Dranishnikova

Shares of Sidus Space, a space services company, advanced nearly 6% on Thursday, November 21, before extending the gains in after-hours trading. This came after the company announced a partnership with the German start-up Reflex Aerospace to produce integrated satellite platforms together. Details On Thursday, Sidus Space stock gained almost…

Read more (~3 min.)

Share

  • Link copied
November 21, 2024

Daktronics stock slips on moves to block activist investor

Maria Dranishnikova

Maria Dranishnikova

Shares of video display and scoreboard manufacturer Daktronics fell over 5% on Wednesday, November 20. This came after it was announced that the company’s board of directors had amended its shareholder rights agreement to prevent an activist investor — a nominee proposed by Alta Fox Capital Management’s affiliates — from…

Read more (~4 min.)

Share

  • Link copied
November 21, 2024

Zacks spotlights Innodata as ‘Palantir in its early days’

Maria Dranishnikova

Maria Dranishnikova

Innodata, a small-cap IT solutions provider that uses its large language models (LLMs) to train other companies’ AI, is like “Palantir in its early days,” according to Zacks. Today, Palantir is a leader in the AI sector with a market capitalization of more than $141.5 billion. Zacks strongly recommends buying…

Read more (~4 min.)

Share

  • Link copied
November 20, 2024

Needham initiates coverage on two air taxi stocks with ‘buys’

Maria Dranishnikova

Maria Dranishnikova

Two air taxi stocks — Joby Aviation and Archer Aviation — have jumped after the investment bank Needham initiated coverage of them with “buy” ratings, as reported by Barron’s.  Details On Tuesday, November 19, Needham launched coverage of Joby Aviation and Archer Aviation, rating them “buys.” This led to a…

Read more (~3 min.)

Share

  • Link copied
November 20, 2024

Zacks raises target price for placenta-based drug maker BioStem

Maria Dranishnikova

Maria Dranishnikova

Zacks Small-Cap Research (Zacks SCR) has raised its target price for BioStem Technologies, a developer of perinatal tissue-based therapies, believing the stock should trade at double its current market price. This comes after the company’s third-quarter financial results, which beat Wall Street expectations. Details Zacks SCR values BioStem Technologies stock…

Read more (~3 min.)

Share

  • Link copied
Latest news
August 27, 2025

Underground gold mining launches at Central Asia’s largest mine

August 26, 2025

Despite expanding nuclear energy, China still leans on coal for electricity

August 22, 2025

Freedom Broker presents investment ideas for fall 2025

August 21, 2025

Weak tenge boosts KazMunayGas revenue

August 19, 2025

Kazakhstanis demonstrate optimism toward banking system while building savings

Новости партнеров
Show more
1 … 4 5 6 7 8 … 20
© 2004-2025. All rights reserved.

The site is registered with the Information Committee, Ministry of Information and Communications of the Republic of Kazakhstan

The information products of this web publishing are intended for persons aged 18 and over

To top
  • About us
  • Confidentiality Policy of Alteco Partners
  • Archive
  • Rules for the processing of personal data
  • Contacts
  • Rules for the use of information